A new study published in The Lancet on Friday indicates that the use of acetaminophen, a widely used pain reliever, during pregnancy is not associated with an increased risk of neurodevelopmental disorders in children. The research analyzed data from a large cohort of pregnant women and their offspring to assess potential long-term effects of the medication.
The findings suggest that pregnant women who used acetaminophen did not have a higher incidence of conditions such as autism spectrum disorder or attention deficit hyperactivity disorder in their children compared to those who did not use the medication. The study provides reassurance to expecting mothers who occasionally need pain relief during pregnancy.
Researchers emphasized that their results support the safety of acetaminophen when used during pregnancy within recommended dosages. However, they also noted the importance of consulting healthcare providers before taking any medication and to consider established medical guidelines.
The study adds to the ongoing discussion about medication safety during pregnancy and underscores the importance of evidence-based guidance for expectant mothers. Further research may continue to explore other factors influencing neurodevelopmental outcomes in children.